✨ Your Portfolio is fetched and updated from zerodha.
Nano FMCG
Market Cap
₹116 Cr.
P/E
19.18
  • Aakaar Medical Techn
  • Kaya

FAQs on Aakaar Medical Technologies Ltd. Shareprice

There is not enough historical data for the companies share price.

There is insufficient historical data to gauge this.
Latest PE of Aakaar Medical Techn is 19.18

Growth Table

  • Aakaar Medical Technologies Ltd.
  • Kaya

Balance Sheet

  • Aakaar Medical Technologies Ltd.
  • Kaya

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Aakaar Medical Technologies Ltd.
  • Kaya

Cash Flow

  • Aakaar Medical Technologies Ltd.
  • Kaya

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Aakaar Medical Technologies Ltd.
  • Kaya

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Aakaar Medical Technologies Ltd. Financials

Aakaar Medical Techn balance sheet is weak and might have solvency issues

The net debt of Aakaar Medical Techn is decreasing.
Latest net debt of Aakaar Medical Techn is ₹11.67 Crs as of Mar-25.
This is less than Mar-24 when it was ₹14.5 Crs.

Yes, profit is increasing.
The profit of Aakaar Medical Techn is ₹6.04 Crs for Mar 2025, ₹2.87 Crs for Mar 2024 and ₹2.15 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aakaar Medical Techn latest dividend payout ratio is 24.38% and 3yr average dividend payout ratio is 24.38%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech